Companies / Arcus Biosciences, Inc.
Arcus Biosciences, Inc.
Financials · FY2025
Ownership
127.3M shares outstanding · as of Jul 30, 2026
Ownership
| Insiders | 3.22% | 4,103,881 |
| 10%+ / strategic | 10.00% | 12,736,927 |
| Institutions | 86.20% | 109,759,922 |
| Public float | 0.58% | 732,646 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Rosen Terry JCEOChief Executive Officer · Director | 1.76% | 2,236,409 |
Jaen Juan C.President | 1.02% | 1,299,252 |
Jarrett JenniferChief Operating Officer | 0.18% | 224,024 |
Tang Carolyn C.FormerGeneral Counsel | 0.12% | 148,734 |
Goeltz II Robert C.Chief Financial Officer | 0.07% | 91,924 |
Markus RichardChief Medical Officer | 0.07% | 89,647 |
Perlman Andrew JDirector | 0.04% | 48,325 |
Falberg Kathryn EDirector | 0.03% | 44,300 |
Machado PatrickDirector | 0.03% | 44,300 |
Azoy AlexanderFormerChief Accounting Officer | 0.03% | 39,581 |
Institutional holders 211
View all →| Holder | Value | % of shares |
|---|---|---|
| $748.85M | 24.68% | |
| $506.11M | 12.89% | |
| $189.76M | 6.25% | |
| $185.89M | 4.74% | |
| $123.65M | 4.08% | |
| $123.55M | 4.07% | |
| $89.83M | 2.96% | |
| $81.25M | 2.95% | |
| $78.16M | 2.58% | |
| $71.66M | 2.36% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $44.78M | +1.5M +31.74% | 6,029,484 4.74% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $43.73M | +1.4M +9.46% | 16,416,249 12.89% of shares | medium |
| Q4 2025 as of | Barclays PLC 13F manager | Add | — | $22.29M | +935K +528.11% | 1,112,258 0.87% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Exit | — | $-19.43M | -816K -100.00% | — | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | — | $-8.58M | -360K -26.45% | 1,000,818 0.79% of shares | medium |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | — | $8.47M | +392K +1198.78% | 424,700 0.33% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | — | $8.07M | +374K +11.03% | 3,761,437 2.95% of shares | medium |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | — | $7.45M | +345K +18.09% | 2,252,367 1.77% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| BlackRock, Inc. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| RCUS | — | 03969F109 |